MedTech ESG Transformation
Client
Leading MedTech company.
Primary Goal
Integrate AI to enhance ESG strategy for tenders and RFPs in European markets.
Vamstar Capability
AI-powered data aggregation and trend analysis
Real-time ESG tracking in tenders and RFPs.
Predictive ESG modelling and insights.
A global MedTech company, with over $10 billion in annual revenue and a workforce of 50,000+, faced increasing customer pressure to align with Environmental, Social, and Governance (ESG) criteria across European markets. The company, which operates across life sciences, instruments, devices, and diagnostics sectors, saw an opportunity to differentiate itself through a proactive ESG strategy in tenders and RFPs.
To meet these growing demands, the company partnered with Vamstar, leveraging its AI-driven platform to analyse historical ESG trends in top-10 EU markets. This initiative was designed to improve market positioning, mitigate risks, and increase margin growth by prioritising sustainability. By using Vamstar’s advanced AI insights, the company aimed to gain a competitive edge and establish itself as a thought leader in ESG initiatives.
The company expected this partnership to significantly enhance visibility into ESG-driven tenders, tailor strategies for country-specific requirements, and improve market share by aligning with sustainability principles.
Key outcomes
500% improvement in ESG tender visibility.
6-9% margin increase from ESG initiatives.
Real-time risk mitigation for ESG changes.
Thought leadership in ESG discussions.
Country-specific ESG strategy development.
Transformation Journey
- Before Vamstar
- During our collaboration
- After
Prior to engaging with Vamstar, the MedTech company faced a fragmented and reactive approach to Environmental, Social, and Governance (ESG) in tenders and RFPs. ESG considerations were becoming increasingly important in European markets, but the company’s processes were largely manual and decentralised. Each market operated independently, leading to inconsistent ESG strategies across regions. The lack of a centralised database or analysis tool meant that critical ESG trends were either missed or responded to too late.
Without a system for tracking emerging ESG requirements, the company found it difficult to identify country-specific priorities. This not only limited their ability to compete effectively but also resulted in missed opportunities where ESG factors could have been leveraged as a differentiator. Resources were stretched thin, with various teams gathering ESG data manually for each tender, which slowed down the process, increased the risk of non-compliance, and limited their success in bids. Moreover, the company’s leadership recognised that their competitors were starting to capitalise on sustainability as a key market driver, leaving them at a disadvantage.
Stakeholder engagement was another challenge. Customers, regulators, and investors increasingly expected strong ESG commitments, but the company was unable to provide comprehensive, data-driven insights into their ESG performance. This lack of proactive communication and data transparency diminished their ability to position themselves as a leader in sustainable healthcare.
Harness AI to drive growth
Take a step towards improving your commercial operations, Register today